People
Biom’up SA announced that Patrice Ferrand was appointed CEO, replacing Dr. Jan Ohrstrom. Dr. Ohrstrom, who was appointed CEO in May of this year, remains Chairman of the Board, a role in which he has served for the Company since 2015.
Microsoft announced that Emma Walmsley, chief executive officer of GlaxoSmithKline, had been nominated to the company’s board of directors.
As Akcea Therapeutics moves forward with a second attempt to gain regulatory approval for Waylivra, it will do so without a number of its C-suite executives.
House Speaker Nancy Pelosi unveiled her plan to lower the prices on up to 250 prescription drugs covered by government-backed plans such as Medicare.
Pulmotect, Inc., a clinical-stage biotechnology company developing an inhaled immunomodulatory agent, is pleased to announce the appointment of Dr. Kumar Srinivasan to its Board of Directors.
Scott Gottlieb, the former commissioner of the U.S. Food and Drug Administration, has joined the board of directors of health-tech company Aetion. This marks the second board of directors the former FDA head has joined this week.
A stigma remains around lung cancer and many people still regard the disease as something of a self-inflicted ailment. But that stigma is waning, new research conducted by the Inova Schar Cancer Institute and Genentech shows.
Late Monday the federal government charged the husband and wife team of Yu Zhou, 49, and Li Chen, 46, with theft of scientific trade secrets from the hospital that focused on exosomes and exosome isolation.
Lysando AG, market leader for antimicrobial proteins based in Liechtenstein, has established an Ethical Committee, composed of two renowned members, who will serve on a voluntary basis, Leonhard Stärk and Dr. Karl Liese.
New CEO to drive international growth of MedEye’s unique medication verification platform
PRESS RELEASES